▶ 調査レポート


• 英文タイトル:Albumin Market Research Report by Source, Type, Application, End User, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19

Albumin Market Research Report by Source, Type, Application, End User, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19「アルブミンのグローバル市場(~2027):動物由来、植物由来」(市場規模、市場予測)調査レポートです。• レポートコード:MRC2303H133
• 出版社/出版日:360iResearch / 2022年10月11日
• レポート形態:英語、PDF、254ページ
• 納品方法:Eメール(受注後2-3日)
• 産業分類:バイオ
• 販売価格(消費税別)
  Single User(1名利用、印刷可)¥643,370 (USD4,949)▷ お問い合わせ
  Enterprise License(企業利用、印刷可)¥1,293,370 (USD9,949)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
360iResearch社の当調査資料によると、2021年に9,248.56百万ドルであった世界のアルブミン市場規模は2022年に10,217.61百万ドルとなり、2027年までに年平均10.65%成長して16,978.40百万ドルまで拡大すると見込まれています。当書は、アルブミンの世界市場を対象とした調査・分析結果をまとめたものであり、序論、調査方法、エグゼクティブサマリー、市場概要、市場インサイト、由来別分析(動物由来、植物由来)、種類別分析(ウシ血清アルブミン、ヒト血清アルブミン、組換えアルブミン)、用途別分析(培養基、薬物送達、治療、ワクチン成分)、エンドユーザー別分析(製薬&バイオテクノロジー、研究機関)、地域別分析(南北アメリカ、アメリカ、カナダ、ブラジル、アジア太平洋、日本、中国、インド、韓国、台湾、ヨーロッパ/中東/アフリカ、イギリス、ドイツ、フランス、ロシア、その他)、競争状況、企業情報などの内容を掲載しています。なお、当書内の企業情報としては、Amgen、Baxalta Incorporated、Baxter International Inc.、Biotest AG、Celgene、China Biologic Products, Inc.、CSL Behring LLC、Grifols SA、Mitsubishi Tanabe Pharma、Novozymes A/S、Octapharma AG、Sigma-Aldrich Co.などが含まれています。

- 動物由来アルブミンの市場規模
- 植物由来アルブミンの市場規模
- ウシ血清アルブミンの市場規模
- ヒト血清アルブミンの市場規模
- 組換えアルブミンの市場規模
- 培養基における市場規模
- 薬物送達における市場規模
- 治療における市場規模
- ワクチン成分における市場規模
- 製薬&バイオテクノロジーにおける市場規模
- 研究機関における市場規模
- 南北アメリカのアルブミン市場規模
- アジア太平洋のアルブミン市場規模
- ヨーロッパ/中東/アフリカのアルブミン市場規模
- その他地域のアルブミン市場規模

The Global Albumin Market size was estimated at USD 9,248.56 million in 2021 and expected to reach USD 10,217.61 million in 2022, and is projected to grow at a CAGR 10.65% to reach USD 16,978.40 million by 2027.

Market Statistics:
The report provides market sizing and forecast across 7 major currencies – USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.

Market Segmentation & Coverage:
This research report categorizes the Albumin to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Source, the market was studied across Animal Sources and Plant Sources.

Based on Type, the market was studied across Bovine Serum Albumin, Human Serum Albumin, and Recombinant Albumin.

Based on Application, the market was studied across Culture Media, Drug Delivery, Therapeutic, and Vaccine Ingredient.

Based on End User, the market was studied across Pharmaceutical & Biotechnology and Research Institutes.

Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:
We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Albumin market considering the current update on the conflict and its global response.

Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Albumin Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:
The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Albumin Market, including Amgen, Baxalta Incorporated, Baxter International Inc., Biotest AG, Celgene, China Biologic Products, Inc., CSL Behring LLC, Grifols SA, Mitsubishi Tanabe Pharma, Novozymes A/S, Octapharma AG, and Sigma-Aldrich Co..

The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:
1. What is the market size and forecast of the Global Albumin Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Albumin Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Albumin Market?
4. What is the competitive strategic window for opportunities in the Global Albumin Market?
5. What are the technology trends and regulatory frameworks in the Global Albumin Market?
6. What is the market share of the leading vendors in the Global Albumin Market?
7. What modes and strategic moves are considered suitable for entering the Global Albumin Market?


1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers Rising utilization of albumin products in non-therapeutic segment Growing number of chronic diseases such as cardiac surgery and infections Awareness of recombinant albumin in vaccine formulations is increasing the demand
5.1.2. Restraints Chances of post-operative risks in patients
5.1.3. Opportunities Emerging research for the development of cost-efficient therapeutics Development of methods for large-scale production of albumin
5.1.4. Challenges Strict government regulations in the approval of albumin-based products
5.2. Cumulative Impact of COVID-19

6. Albumin Market, by Source
6.1. Introduction
6.2. Animal Sources
6.3. Plant Sources

7. Albumin Market, by Type
7.1. Introduction
7.2. Bovine Serum Albumin
7.3. Human Serum Albumin
7.4. Recombinant Albumin

8. Albumin Market, by Application
8.1. Introduction
8.2. Culture Media
8.3. Drug Delivery
8.4. Therapeutic
8.5. Vaccine Ingredient

9. Albumin Market, by End User
9.1. Introduction
9.2. Pharmaceutical & Biotechnology
9.3. Research Institutes

10. Americas Albumin Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States

11. Asia-Pacific Albumin Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam

12. Europe, Middle East & Africa Albumin Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom

13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.1.1. Quadrants
13.1.2. Business Strategy
13.1.3. Product Satisfaction
13.2. Market Ranking Analysis, By Key Player
13.3. Market Share Analysis, By Key Player
13.4. Competitive Scenario
13.4.1. Merger & Acquisition
13.4.2. Agreement, Collaboration, & Partnership
13.4.3. New Product Launch & Enhancement
13.4.4. Investment & Funding
13.4.5. Award, Recognition, & Expansion

14. Company Usability Profiles
14.1. Amgen
14.1.1. Business Overview
14.1.2. Key Executives
14.1.3. Product & Services
14.2. Baxalta Incorporated
14.2.1. Business Overview
14.2.2. Key Executives
14.2.3. Product & Services
14.3. Baxter International Inc.
14.3.1. Business Overview
14.3.2. Key Executives
14.3.3. Product & Services
14.4. Biotest AG
14.4.1. Business Overview
14.4.2. Key Executives
14.4.3. Product & Services
14.5. Celgene
14.5.1. Business Overview
14.5.2. Key Executives
14.5.3. Product & Services
14.6. China Biologic Products, Inc.
14.6.1. Business Overview
14.6.2. Key Executives
14.6.3. Product & Services
14.7. CSL Behring LLC
14.7.1. Business Overview
14.7.2. Key Executives
14.7.3. Product & Services
14.8. Grifols SA
14.8.1. Business Overview
14.8.2. Key Executives
14.8.3. Product & Services
14.9. Mitsubishi Tanabe Pharma
14.9.1. Business Overview
14.9.2. Key Executives
14.9.3. Product & Services
14.10. Novozymes A/S
14.10.1. Business Overview
14.10.2. Key Executives
14.10.3. Product & Services
14.11. Octapharma AG
14.11.1. Business Overview
14.11.2. Key Executives
14.11.3. Product & Services
14.12. Sigma-Aldrich Co.
14.12.1. Business Overview
14.12.2. Key Executives
14.12.3. Product & Services

15. Appendix
15.1. Discussion Guide
15.2. License & Pricing